文献速递肺结节与肺癌

完全切除非小细胞肺癌部位特异性复发条件风险网络列线图的开发与验证:多中心研究

Development and Validation of Web-Based Nomograms to Precisely Predict Conditional Risk of Site-Specific Recurrence for Patients With Completely Resected Non-small Cell Lung Cancer: A Multiinstitutional Study.
PubMed 文献 · Chest · 2018-06-18

本研究基于2,017例完全切除的非小细胞肺癌(NSCLC)患者开发网络列线图,用于预测部位特异性复发的条件风险,并在3,308例外部队列中验证。列线图预测总复发及胸部、腹部、颈部、脑、骨复发的C统计量在开发队列为0.743至0.787,外部验证队列为0.703至0.784,校准良好。工具可辅助制定个体化术后随访策略。

要点

  • 基于性别、年龄、吸烟史、肿瘤大小、组织学、脉管侵犯、胸膜侵犯和病理TNM分期构建列线图。
  • 列线图可预测总复发及胸部、腹部、颈部、脑、骨部位特异性复发的条件风险。
  • 外部验证显示良好区分度和校准度,有助于个体化术后随访计划。

核心结论

  • 基于临床病理特征开发的网络列线图能精确预测完全切除NSCLC患者的部位特异性复发,并可能帮助医生制定个体化术后随访计划。

研究设计与样本

  • 多中心研究,开发队列为复旦大学附属肿瘤医院2,017例完全切除的NSCLC患者(鳞癌和非贴壁型浸润性腺癌),外部验证队列为上海市胸科医院3,308例NSCLC患者。
  • 基于Cox回归开发网络列线图,预测条件风险;分析变量包括性别、年龄、吸烟史、肿瘤大小、肿瘤组织学、脉管侵犯、脏层胸膜侵犯和病理TNM分期。

主要发现

  • 开发队列和外部验证队列预测总复发的C统计量分别为0.743和0.748。
  • 预测胸部复发的C统计量分别为0.728和0.703,腹部复发为0.760和0.749,颈部复发为0.779和0.757,脑复发为0.787和0.784,骨复发为0.777和0.739。
  • 校准图显示列线图预测的3年无复发生存与实际3年无复发生存之间具有最佳一致性。

临床怎么用

  • 列线图可基于常规临床病理特征预测完全切除NSCLC患者的部位特异性复发风险,辅助个体化随访策略的制定,包括随访时机和诊断检查选择。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: There is currently no consensus regarding the optimal postoperative follow-up strategy for patients with completely resected non-small cell lung cancer (NSCLC). We aimed to develop web-based nomograms to precisely predict site-specific postoperative recurrence in patients with NSCLC and to guide individual surveillance strategies including when to follow up and what diagnostic tests to perform. METHODS: We investigated the pattern of recurrence in a series of 2,017 patients with NSCLC (squamous cell carcinoma and nonlepidic invasive adenocarcinoma) who underwent complete surgical resection at Fudan University Shanghai Cancer Center (development cohort), and developed web-based clinicopathologic prediction models for conditional risk of site-specific recurrence based on Cox regression. The variables used in the analysis included sex, age, smoking history, tumor size, tumor histology, lymphovascular invasion, visceral pleural invasion, and pathologic TNM stage. A separate cohort of 3,308 patients with NSCLC from Shanghai Chest Hospital was used for external validation. RESULTS: In the development cohort and the external validation cohort for the established nomograms to predict overall recurrence, thorax recurrence, abdomen recurrence, neck recurrence, brain recurrence, and bone recurrence, the C-statistics of Harrell et al were 0.743 and 0.748, 0.728 and 0.703, 0.760 and 0.749, 0.779 and 0.757, 0.787 and 0.784, and 0.777 and 0.739, respectively. The calibration plots showed optimal agreement between nomogram-predicted 3-year recurrence-free survival and actual 3-year recurrence-free survival. CONCLUSIONS: These user-friendly nomograms can precisely predict site-specific recurrence in patients with completely resected NSCLC, based on clinicopathologic features. They may help physicians to make individual postoperative follow-up plans.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Zhang Y, Zheng D, Xie J, et al. Development and Validation of Web-Based Nomograms to Precisely Predict Conditional Risk of Site-Specific Recurrence for Patients With Completely Resected Non-small Cell Lung Cancer: A Multiinstitutional Study. Chest. 2018. PMID: 29758181. doi:10.1016/j.chest.2018.04.040

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。